The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. (Q52726729)
Jump to navigation
Jump to search
scientific article published on 8 January 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. |
scientific article published on 8 January 2018 |
Statements
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. (English)
Jianwen Dong
Soon Young Park
Nghi Nguyen
Ravesanker Ezhilarasan
Emmanuel Martinez-Ledesma
Shaofang Wu
Verlene Henry
Yuji Piao
Ningyi Tiao
David Brunell
Clifford Stephan
Roel Verhaak
Erik Sulman
Veerakumar Balasubramaniyan
John F de Groot
8 January 2018
9
12
10497-10509
Limma